Andere Sprachen Newbury Pharmaceuticals AB

Aktien

A3DDU5

SE0015244884

NEWBRY

Verzögert Nasdaq Stockholm Andere Börsenplätze 12:34:04 07.06.2024			% 5 Tage	% 1. Jan.
3.16 ^SEK	+7.48%		+1.97%	+0.98%

10.04.	Newbury Pharmaceuticals AB (publ) meldet die Ergebnisse für das zweite Quartal und die sechs Monate bis zum 29. Februar 2024	CI
22.02.	Newbury Pharmaceuticals sichert sich einen Auftrag in Höhe von 9 Millionen SEK	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Newbury Pharmaceuticals Q2 - A bump in the road	11.04.
Newbury Pharmaceuticals interim report September 2023 – February 2024	10.04.
Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	10.04.
Newbury Pharmaceuticals carries out a directed share issue of approximately SEK 19 million	04.03.
Newbury Pharmaceuticals Secures SEK9 Million Sales Order	22.02.
Newbury Pharmaceuticals receives international sales order valued at 8.8 million SEK	22.02.
Newbury Pharmaceuticals Receives International Sales Order Valued At 8.8 Million	22.02.
Nintedanib Newbury approved by the Swedish Health Authorities	17.01.
Newbury Pharmaceuticals Q1 Report - Ramp-up in sales	11.01.
ANNUAL GENERAL MEETING OF SHAREHOLDERS IN NEWBURY PHARMACEUTICALS AB	10.01.
Newbury Pharmaceuticals interim report September 2023 – November 2023	10.01.
Newbury Pharmaceuticals AB Reports Earnings Results for the First Quarter Ended November 30, 2023	10.01.
Newbury Pharmaceuticals publishes its annual report for 2022/2023	13.12.
Kallelse till årsstämma i Newbury Pharmaceuticals AB	08.12.
Newbury Pharmaceuticals is strengthening its portfolio with Melatonin Extended Release 2 mg	20.10.23
Newbury Pharmaceuticals Q4 Report - Bolstered business	12.10.23
Newbury Pharmaceuticals year-end report September 2022 – August 2023	11.10.23
Newbury Pharmaceuticals AB Reports Earnings Results for the Full Year Ended August 31, 2023	11.10.23
Newbury Pharmaceuticals AB Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	11.10.23
Newbury, Amarox Sign Distribution Deal for Sweden, Denmark	06.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Newbury Pharmaceuticals AB

Aktien

A3DDU5

SE0015244884

NEWBRY

Andere Sprachen

Filter